EUVIMEDEUVIMED entdecken
Crossref

Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death

Prasath Manogaran, Aparna Anandan, Viswanadha Vijaya Padma

Journal of Biochemical and Molecular Toxicology · 2023

DOI: 10.1002/jbt.23395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Prasath Manogaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Bharathiar University, Coimbatore, India. Hauptthemen laut MEDLINE: Paclitaxel, Colonic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previously we have reported the isoliensinine (ISO) potentates the therapeutic potential of cisplatin in cisplatin resistant colorectal cancer stem cells. The present study evaluates the chemo‐sensitizing potential of the combinatorial regimen of ISO and Paclitaxcel (PTX) on multidrug‐resistant (MDR)‐HCT‐15 cells to reduce the dose requirement of both ISO and PTX. The results of the present study suggest that treatment with the combinatorial regimen of ISO and PTX enhanced the cytotoxic effect with resultant increase in apoptosis in MDR‐HCT‐15 cells as evident from the altered cellular morphology, G2/M cell cycle arrest, propidium iodide uptake, Annexin V, increased intracellular Ca 2+ accumulation, decreased mitochondrial membrane potential, diminished ATP production, PARP‐1 cleavage, altered expression of ERK1/2, and apoptotic proteins. Treatment with combinatorial regimen of ISO and PTX also modulated the expression of the transcription factors SOX2, OCT4 which determine the stemness of cancer cells. Thus, results of the present study suggest that ISO and PTX combination regimen induces apoptosis in MDR‐HCT‐15 in a synergistic manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelColonic NeoplasmsHumansCisplatinDrug Resistance, NeoplasmNeoplastic Stem CellsCell DeathApoptosisMitochondriaCell Line, TumorIsoquinolines

Stichwörter der Autor:innen

MDRcolorectal cancer HCT-15 cellsisoliensinine (ISO)paclitaxel (PTX)

Substanzen

PaclitaxelCisplatinisoliensinineIsoquinolines

Autor:innen und Institutionen

  • Department of Biotechnology, Bharathiar University, Coimbatore, India.

Zitieren

APA

Manogaran, P., Anandan, A., & Vijaya Padma, V. (2023). Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23395

Vancouver

Manogaran P, Anandan A, Vijaya Padma V. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23395

BibTeX
@article{Manogaran2023,
  author = {Manogaran, Prasath and Anandan, Aparna and Vijaya Padma, Viswanadha},
  title = {Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  doi = {10.1002/jbt.23395}
}
Kostenlos starten →